{"id":83859,"date":"2026-01-29T13:18:39","date_gmt":"2026-01-29T13:18:39","guid":{"rendered":"https:\/\/www.cofb.org\/?p=83859"},"modified":"2026-01-29T13:18:39","modified_gmt":"2026-01-29T13:18:39","slug":"bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","title":{"rendered":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix"},"content":{"rendered":"\n

El Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> va acollir, el passat 22 de gener, la sessi\u00f3 formativa \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic<\/strong>\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya<\/a>. La formaci\u00f3 va anar a c\u00e0rrec de Natalia Zaldua<\/strong>, del departament cient\u00edfic i formatiu de Microcaya i experta en bioimped\u00e0ncia InBody<\/strong>; i de Carla Escuder<\/strong>, farmac\u00e8utica comunit\u00e0ria i dietista-nutricionista experta en nutrici\u00f3 esportiva. El vocal d\u2019Alimentaci\u00f3 i Nutrici\u00f3 de COFB, Oscar Llans\u00f3<\/strong>, va coordinar i moderar la formaci\u00f3 adre\u00e7ada a farmac\u00e8utics i farmac\u00e8utiques de farm\u00e0cia comunit\u00e0ria.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Els objectius<\/strong> de la formaci\u00f3 van ser revisar les eines per implementar protocols de consell alimentari<\/strong>, con\u00e8ixer el funcionament i \u00fas de la bioimped\u00e0ncia i donar el millor consell<\/strong> i realitzar correctament la recomanaci\u00f3 nutricional <\/strong>d\u2019acord amb la composici\u00f3 corporal.<\/p>\n\n\n\n

El vocal d’Alimentaci\u00f3 i Nutrici\u00f3 va presentar la formaci\u00f3, explicant que la bioimped\u00e0ncia \u201cofereix informaci\u00f3 vital sobre la composici\u00f3 corporal<\/strong>, incloent-hi percentatges de greix, massa muscular, aigua corporal i altres indicadors com l\u2019angle de fase, que s\u00f3n essencials per a la salut i per un bon seguiment en l\u2019\u00e0mbit esportiu\u201d.<\/p>\n\n\n\n

A m\u00e9s, va recordar que \u201c\u00e9s el segon any que es duu a terme aquesta formaci\u00f3, que comptar\u00e0 amb una primera part te\u00f2rica i una altra de pr\u00e0ctica, amb un analitzador de composici\u00f3 corporal InBody\u201d.<\/p>\n\n\n\n

Qu\u00e8 \u00e9s i qu\u00e8 ofereix la bioimped\u00e0ncia<\/h2>\n\n\n\n

En l’inici de la seva sessi\u00f3, Carla Escuder<\/strong> va explicar que \u201cel pes total del cos no ho \u00e9s tot, sin\u00f3 que la clau est\u00e0 a analitzar la composici\u00f3 total del cos<\/strong> i dels compartiments que el conformen\u201d. Despr\u00e9s de mostrar imatges de dues noies amb un pes id\u00e8ntic<\/strong>, per\u00f2 amb difer\u00e8ncies corporals<\/strong>, la farmac\u00e8utica comunit\u00e0ria va confirmar que \u201cla seva composici\u00f3 \u00e9s totalment diferent i tamb\u00e9 el seu estat de salut. A causa d\u2019aix\u00f2, \u00e9s clau mesurar m\u00e9s enll\u00e0 del pes total\u201d.<\/p>\n\n\n\n

A continuaci\u00f3, va descriure la bioimped\u00e0ncia com \u201cuna t\u00e8cnica que es fonamenta en el principi que els teixits corporals tenen diferents conductivitats el\u00e8ctriques<\/strong>. Els primers dispositius per a la bioimped\u00e0ncia eren rudimentaris, per\u00f2 amb el temps es va millorar la tecnologia. Els investigadors van comen\u00e7ar a integrar-la en \u00e0mbits com la nutrici\u00f3, l’esport i la medicina<\/strong>\u201d.<\/p>\n\n\n\n

\"Carla<\/a>
Carla Escuder durant la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Escuder va afirmar que l\u2019\u00cdndex de Massa Corporal (IMC) est\u00e0 ja obsolet, i va dir que, avui dia, la composici\u00f3 corporal \u00e9s \u201cel terme que es fa servir per descriure la proporci\u00f3 dels diferents components que formen el cos hum\u00e0, incloent-hi la massa muscular, la massa de greix, l’aigua i altres teixits\u201d.<\/strong><\/p>\n\n\n\n

Aquesta an\u00e0lisi que ofereix la bioimped\u00e0ncia \u201cpermet identificar quina quantitat<\/strong>, aix\u00ed com la distribuci\u00f3<\/strong> d’aquests components<\/strong>. Una composici\u00f3 corporal equilibrada, amb una proporci\u00f3 saludable de massa magra i greix corporal, \u00e9s essencial per al funcionament \u00f2ptim del cos i per prevenir malalties cr\u00f2niques\u201d.<\/p>\n\n\n\n

An\u00e0lisi del greix corporal i interpretaci\u00f3 de resultats<\/h2>\n\n\n\n

Pel que fa a la part pr\u00e0ctica de la formaci\u00f3, Natalia Zaldua<\/strong> va explicar com interpretar els fulls de resultats lligats a l\u2019\u00cdndex de Massa Musculoesquel\u00e8tica Apendicular<\/strong> (IMMEA): \u201caquest par\u00e0metre \u00e9s la suma de la massa magra dels bra\u00e7os<\/strong> i les cames <\/strong>entre l’al\u00e7ada del quadrat<\/strong>. Es tracta d’un \u00edndex que reflecteix el desenvolupament muscular<\/strong> i \u00e9s emprat en la detecci\u00f3 de patologies com ara la sarcop\u00e8nia\u201d.<\/p>\n\n\n\n

\"Natalia<\/a>
Natalia Zaldua en un moment de la seva intervenci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Amb relaci\u00f3 a l\u2019an\u00e0lisi del greix corporal<\/strong>, \u201caquest es divideix en greix subcutani i greix visceral<\/strong>. Aquest segon \u00e9s el que envolta els \u00f2rgans i que serveix per protegir-los. \u00c9s una reserva energ\u00e8tica i un exc\u00e9s planteja riscos. L’ideal \u00e9s tenir una \u00e0rea de greix visceral inferior al 100%\u201d. A partir d\u2019aqu\u00ed, l\u2019experta en bioimped\u00e0ncia InBody va posar a prova a tots els farmac\u00e8utics presents a trav\u00e9s de la interpretaci\u00f3 del full de resultats <\/strong>de l\u2019analitzador InBody i l\u2019avaluaci\u00f3 de les alteracions a l\u2019equilibri h\u00eddric<\/strong>, entre d\u2019altres.<\/p>\n\n\n\n

Per finalitzar, Zaldua va realitzar diferents recomanacions antiinflamat\u00f2ries <\/strong>que poden patir diferents usuaris, destacant \u201cconsolidar el moviment diari i l\u2019exercici f\u00edsic, la gesti\u00f3 de l\u2019estr\u00e8s, dur a terme el descans adequat, i la regulaci\u00f3 dels ritmes circadiaris, com \u00e9s evitar l\u2019\u00fas de pantalles abans d\u2019anar a dormir i l\u2019exposici\u00f3 de llum natural durant el mat\u00ed\u201d.<\/p>\n\n\n\n

Amb la col\u00b7laboraci\u00f3 de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir, el passat 22 de gener, la sessi\u00f3 formativa \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya. La formaci\u00f3 va anar a c\u00e0rrec de Natalia Zaldua, del departament cient\u00edfic i formatiu de Microcaya i experta en bioimped\u00e0ncia InBody; i de Carla […]<\/p>\n","protected":false},"author":10,"featured_media":83892,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[36,5254,18,19,5434,271,53,70,46,76],"class_list":["post-83859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio","tag-bioimpedancia","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-composicio-corporal","tag-consell-alimentari","tag-farmaceutics","tag-formacio","tag-nutricio","tag-oficina-de-farmacia"],"yoast_head":"\nBioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-29T13:18:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix\",\"datePublished\":\"2026-01-29T13:18:39+00:00\",\"dateModified\":\"2026-01-29T13:18:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"},\"wordCount\":777,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"keywords\":[\"alimentaci\u00f3\",\"bioimped\u00e0ncia\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"composici\u00f3 corporal\",\"consell alimentari\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"Nutrici\u00f3\",\"Oficina de farm\u00e0cia\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\",\"name\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"datePublished\":\"2026-01-29T13:18:39+00:00\",\"dateModified\":\"2026-01-29T13:18:39+00:00\",\"description\":\"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","og_locale":"ca_ES","og_type":"article","og_title":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","og_url":"https:\/\/www.cofb.org\/ca\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-01-29T13:18:39+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Xavier Magraner","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix","datePublished":"2026-01-29T13:18:39+00:00","dateModified":"2026-01-29T13:18:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"},"wordCount":777,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","keywords":["alimentaci\u00f3","bioimped\u00e0ncia","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","composici\u00f3 corporal","consell alimentari","farmac\u00e8utics","Formaci\u00f3","Nutrici\u00f3","Oficina de farm\u00e0cia"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","url":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/","name":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","datePublished":"2026-01-29T13:18:39+00:00","dateModified":"2026-01-29T13:18:39+00:00","description":"El passat 22 de gener, el COFB va organitzar la confer\u00e8ncia \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya.","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/01\/29\/bioimpedancia-en-el-consell-farmaceutic-que-es-i-que-ens-ofereix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Bioimped\u00e0ncia en el consell farmac\u00e8utic. Qu\u00e8 \u00e9s i qu\u00e8 ens ofereix"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/01\/1769085793370-1-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El Col\u00b7legi de Farmac\u00e8utics de Barcelona va acollir, el passat 22 de gener, la sessi\u00f3 formativa \u201cBioimped\u00e0ncia en el consell farmac\u00e8utic\u201d, amb la col\u00b7laboraci\u00f3 de Microcaya. La formaci\u00f3 va anar a c\u00e0rrec de Natalia Zaldua, del departament cient\u00edfic i formatiu de Microcaya i experta en bioimped\u00e0ncia InBody; i de Carla […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/83859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=83859"}],"version-history":[{"count":24,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/83859\/revisions"}],"predecessor-version":[{"id":83936,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/83859\/revisions\/83936"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/83892"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=83859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=83859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=83859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}